Posted by Michael Wonder on 16 Dec 2025
Leo Pharma submits adolescent label expansion application for Anzupgo to EMA
15 December 2025 - Leo Pharma today announced submission of a label expansion application to the EMA to expand the use of Anzupgo (delgocitinib) cream to adolescents aged 12 to 17 years, living with moderate to severe chronic hand eczema for whom topical corticosteroids are inadequate or inappropriate in the European Union.
The label expansion application has been accepted for review by EMA.
